Literature DB >> 17079182

Regulation of corneal angiogenesis in limbal stem cell deficiency.

David Hui-Kang Ma1, Jan-Kan Chen, Fen Zhang, Kuei-Ying Lin, Jeng-Yuan Yao, Jau-Song Yu.   

Abstract

Corneal angiogenesis is associated with a variety of corneal diseases, and is sometimes vision threatening. In recent years, with the discovery of major pro- and anti-angiogenic factors in the cornea, details of the angiogenic process are gradually unveiled. Of note, corneal inflammation and neovascularization associated with severe limbal stem cell (LSC) deficiency is a clinically challenging issue in that the condition persists long after the initial insult, and will not improve without transplantation of LSCs. However, to date the molecular mechanism by which LSC transplantation restores corneal avascularity is not fully understood. In addition to discussing major pro-angiogenic factors involved in corneal neovascularization, this review article also focuses on possible molecular mechanisms underlying persistent inflammation and neovascularization following severe LSC deficiency, and anti-angiogenic factors expressed by human limbo-corneal epithelial cells (HLCECs). Most of the recently discovered corneal anti-angiogenic factors belong to extracellular matrix proteins that acquire angio-inhibitory activity only after proper proteolytic processing. Our recent findings showed that the secretion of endostatin (derived from basement membrane collagen XVIII) and restin (from collagen XV) by HLCECs were enhanced when HLCECs were cultivated on amniotic membrane (AM). This adds to the advantage of transplanting ex vivo expanded HLCECs cultivated on AM in that the anti-angiogenic activity of the epithelial cells is augmented in a physiological way. Furthermore, proteomic profiling of HLCECs and human conjunctival epithelial cells (HCECs) identified a 14-3-3 protein (stratifin) preferentially expressed by HLCECs. In addition to functioning as a cell cycle controller, keratinocyte-derived stratifin induces MMPs which are involved in the generation of restin (by MMP-1) and endostatin (by MMP-3). These findings highlight the significance of delicate epithelial-matrix interactions in the maintenance of corneal avascularity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079182     DOI: 10.1016/j.preteyeres.2006.09.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  17 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Fabrication and characters of a corneal endothelial cells scaffold based on chitosan.

Authors:  Ye Liang; Wanshun Liu; Baoqin Han; Chaozhong Yang; Qun Ma; Weiwei Zhao; Mi Rong; Hui Li
Journal:  J Mater Sci Mater Med       Date:  2010-11-25       Impact factor: 3.896

3.  Estrogen therapy to treat retinopathy in newborn mice.

Authors:  Wenjing Shi; L I Zhu; Yuhuan Wang; Baoyang Hu; Honglei Xiao; Guoming Zhou; Chao Chen
Journal:  Exp Ther Med       Date:  2015-06-05       Impact factor: 2.447

4.  Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.

Authors:  Sudha Swamynathan; Chelsea L Loughner; Shivalingappa K Swamynathan
Journal:  Exp Eye Res       Date:  2017-08-10       Impact factor: 3.467

5.  Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.

Authors:  Hai-Tao Du; Ling-Ling Du; Xian-Ling Tang; Hong-Yan Ge; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

6.  Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization.

Authors:  Zhang Chaoran; Lin Zhirong; Xu Gezhi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-15       Impact factor: 3.117

Review 7.  Molecular underpinnings of corneal angiogenesis: advances over the past decade.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 8.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 9.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

Review 10.  Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Authors:  David Ellenberg; Dimitri T Azar; Joelle A Hallak; Faisal Tobaigy; Kyu Yeon Han; Sandeep Jain; Zhongjun Zhou; Jin-Hong Chang
Journal:  Prog Retin Eye Res       Date:  2010-01-25       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.